Abstract
In recent years, numerous changes have been made in the field of cancer research with the progresses of molecular biology, chemoinformatics and chemogenomics. Several new biomolecular targets have been identified, and investigated for new drug discovery. In the current article, we discuss the role of pharmacophore mapping and pharmacophorebased virtual screening (PBVS) approaches for identification of novel anticancer hits. It showed that pharmacophorebased studies were performed for almost every type of anticancer agents. However, such applications are clustered on finding novel hits for a few targets like cancer-related hormones, kinase enzymes and other less investigated targets. Some reports were found with virtual hits experimentally validated against respective targets. These were thoroughly described and the novel hits were pointed out. Others with PBVS of anticancer targets were also discussed and the identified features were highlighted. Present review showed that PBVS may serve as a true lead generator if it is performed in a unified fashion that combines in silico techniques with experimental validation. With enormous progresses in computational methods as well as molecular biology, it is expected that pharmacophore-based drug discovery strategy will aid in significant upsurge in the field of cancer chemotherapy in near future.
Keywords: Cancer, Cheminformatics, Pharmacophore mapping, Virtual screening, Kinase, Lead identification.
Current Topics in Medicinal Chemistry
Title:The Role of 3D Pharmacophore Mapping Based Virtual Screening for Identification of Novel Anticancer Agents: An Overview
Volume: 13 Issue: 9
Author(s): Amit K. Halder, Achintya Saha and Tarun Jha
Affiliation:
Keywords: Cancer, Cheminformatics, Pharmacophore mapping, Virtual screening, Kinase, Lead identification.
Abstract: In recent years, numerous changes have been made in the field of cancer research with the progresses of molecular biology, chemoinformatics and chemogenomics. Several new biomolecular targets have been identified, and investigated for new drug discovery. In the current article, we discuss the role of pharmacophore mapping and pharmacophorebased virtual screening (PBVS) approaches for identification of novel anticancer hits. It showed that pharmacophorebased studies were performed for almost every type of anticancer agents. However, such applications are clustered on finding novel hits for a few targets like cancer-related hormones, kinase enzymes and other less investigated targets. Some reports were found with virtual hits experimentally validated against respective targets. These were thoroughly described and the novel hits were pointed out. Others with PBVS of anticancer targets were also discussed and the identified features were highlighted. Present review showed that PBVS may serve as a true lead generator if it is performed in a unified fashion that combines in silico techniques with experimental validation. With enormous progresses in computational methods as well as molecular biology, it is expected that pharmacophore-based drug discovery strategy will aid in significant upsurge in the field of cancer chemotherapy in near future.
Export Options
About this article
Cite this article as:
Halder Amit K., Saha Achintya and Jha Tarun, The Role of 3D Pharmacophore Mapping Based Virtual Screening for Identification of Novel Anticancer Agents: An Overview, Current Topics in Medicinal Chemistry 2013; 13 (9) . https://dx.doi.org/10.2174/1568026611313090009
DOI https://dx.doi.org/10.2174/1568026611313090009 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cancer Chemoprevention by Targeting the Epigenome
Current Drug Targets Pharmacokinetics of Polymeric Micelles for Cancer Treatment
Current Drug Metabolism Nanoparticle-Derived Non-Viral Genetic Transfection at the Blood-Brain Barrier to Enable Neuronal Growth Factor Delivery by Secretion from Brain Endothelium
Current Medicinal Chemistry Immunotherapeutic Options for Pediatric Malignancies
Current Immunology Reviews (Discontinued) Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents
Current Medicinal Chemistry Isolation, Purification and Characterization of a Novel Steroidal Saponin Cholestanol Glucoside from Lasiodiplodia theobromae that Induces Apoptosis in A549 Cells
Anti-Cancer Agents in Medicinal Chemistry Methods to Assess Tissue-Specific Distribution and Metabolism of Drugs
Current Drug Metabolism In Vitro High Throughput Phage Display Selection of Ovarian Cancer Avid Phage Clones for Near-Infrared Optical Imaging
Combinatorial Chemistry & High Throughput Screening Driving Cellular Plasticity and Survival Through the Signal Transduction Pathways of Metabotropic Glutamate Receptors
Current Neurovascular Research Pharmacological Perspectives of Wasp Venom
Protein & Peptide Letters Interaction of Endocannabinoid Receptors with Biological Membranes
Current Medicinal Chemistry Metal-N-Heterocyclic Carbene Complexes as Anti-Tumor Agents
Current Medicinal Chemistry Anticancer Drug Design Using Scaffolds of β-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials
Current Medicinal Chemistry Blockade of Ser16-Hsp20 Phosphorylation Attenuates Neuroprotection Dependent Upon Bcl-2 and Bax
Current Neurovascular Research Trends in Malignant Glioma Monoclonal Antibody Therapy
Current Cancer Therapy Reviews Melatonin and Melatoninergic Drugs as Therapeutic Agents: Ramelteon and Agomelatine, the Two Most Promising Melatonin Receptor Agonists
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Cancer Immunotherapy: The Role Regulatory T Cells Play and What Can be Done to Overcome their Inhibitory Effects
Current Molecular Medicine The Relationship Between Epilepsy and Depression: An Update
Current Medicinal Chemistry The Application of Nanomaterials in Stem Cell Therapy for Some Neurological Diseases
Current Drug Targets Modulation of Tumour-Related Signaling Pathways by Natural Pentacyclic Triterpenoids and their Semisynthetic Derivatives
Current Medicinal Chemistry